Alkahest
is a biopharmaceutical company that provides treatments for neurodegenerative and age-related diseases... Read moreAlkahest
is a biopharmaceutical company that provides treatments for neurodegenerative and age-related diseases... Read more
News
Jun 26, 2024
IGN Entertainment
Alkahest: Alkahest Is a New First-Person Medieval Fantasy Action-RPG that Looks Stunning
Mar 08, 2021
Benzinga
Alkahest: Alkahest to Present Positive Data from Completed Phase 2 Clinical Trial at the 15th International Conference on Alzheimer's and Parkinson's Disease
Jan 28, 2021
GlobalNewswire
Press Release: Alkahest : Alkahest Announces Peer-Reviewed Publication Demonstrating Safety and Tolerability of GRF6019 in Patients with Mild-to-Moderate Alzheimer's Disease
Sep 09, 2020
Contract Pharma
Alkahest: Grifols to Acquire Alkahest for $146M
Sep 08, 2020
The Business Journals: San Francisco Business Times
Alkahest: Spanish company buys out Peninsula 'young blood' company for $146M
Jul 09, 2020
GlobeNewswire
Press Release: Alkahest : Alkahest Provides Corporate Update
Jun 01, 2020
MarketScreener
Alkahest: Alkahest Announces Initiation of Phase 2 Study AKST1210-201 Exploring Treatment of Cognitive Impairment in End Stage Renal Disease Patients
Feb 10, 2020
GlobeNewswire
Press Release: Alkahest : Alkahest Announces Initiation of Phase 2b Clinical Trial of AKST4290 in Patients with Treatment-Naïve Wet Age-Related Macular Degeneration
Feb 04, 2020
MarketScreener
Alkahest: Alkahest Initiates a Phase 2 Clinical Trial of AKST4290 in Parkinson's Disease with Funding from The Michael J. Fox Foundation
Dec 09, 2019
GlobeNewswire
Press Release: Alkahest : Alkahest Presents Data from Phase 2a Study in Mild-to-Moderate Alzheimer's Disease
Alkahest Competitors
1
2
3
4
5
6
7
8
9
10